Search results
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 hour agoBio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript May 1, 2024 Bio-Techne...
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 1 day agoTechne (TECH) delivered earnings and revenue surprises of 4.35% and 3.77%, respectively, for the...
Earnings call: Bio-Techne sees growth in Q3 with strong market positioning
Investing.com· 11 hours agoBio-Techne (NASDAQ: TECH ) Corporation ( NASDAQ : TECH) reported a 2% year-over-year organic revenue...
Techne (TECH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo Finance· 1 day agoThe headline numbers for Techne (TECH) give insight into how the company performed in the quarter...
Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 25% Above Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 23 hours agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Bio-Techne fair value estimate is US$50.46...
Bio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market Challenges
GuruFocus.com via Yahoo Finance· 1 day agoOperating Margin: Adjusted operating margin recorded at 33.0%, a decrease from 37.0% in the previous year, impacted by acquisition costs and volume leverage. On May 1, 2024, Bio-Techne ...
Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here’s Why.
Barrons.com· 22 hours agoSTOCK ALERT Bio-Techne stock was surging Wednesday after the biotechnology company reported better...
BIO-TECHNE DECLARES DIVIDEND
FOX 5 San Diego· 1 day agoBio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2024. The quarterly ...
Bio-Techne Sees Signs of Recovery as Biopharma, China Headwinds Wane in Fiscal Q3
GenomeWeb News· 1 day agoAfter multiple quarters of headwinds from lower biopharmaceutical funding and macroeconomic concerns in China, Bio-Techne is starting to see positive developments across its ...
Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ...
GuruFocus.com via Yahoo Finance· 8 hours agoDespite mixed segment performance and macroeconomic pressures, TECH maintains a robust strategic outlook with key advancements in diagnostics and genomics.
